サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566825

外部鼻孔拡張器市場：用途別、エンドユーザー別、流通チャネル別：世界の機会分析と産業予測、2024～2033年

External Nasal Dilator Market By Application (Snoring, Sleep apnea, Nasal congestion, Others) , By End User (Adults, Pediatric) By Distribution Channel (Offline, Online) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.12円
外部鼻孔拡張器市場：用途別、エンドユーザー別、流通チャネル別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

外部鼻孔拡張器の世界市場は、2023年に9,830万米ドルと評価され、2024～2033年にかけてCAGR 5.1％で成長し、2033年には1億6,240万米ドルに達すると予測されています。

外部鼻孔拡張器は、鼻腔を外側から緩やかに開くことによって鼻腔の気流を高めるように設計された革新的な装置です。この装置は、睡眠時無呼吸症候群、鼻づまり、いびき、または運動時の呼吸を改善したい人に特に有益です。外部鼻孔拡張器は、呼吸と一般的な健康を改善するために、気流の制約を緩和するように設計されています。

外部鼻孔拡張器の世界市場の成長は、睡眠時無呼吸症候群の有病率の急増、鼻づまり、いびき、または運動時の呼吸を改善したい人のための外部鼻孔拡張器の人気と採用の増加などのいくつかの要因によって駆動されます。さらに、アレルギー、風邪、副鼻腔炎、解剖学的異常は鼻づまりの主要原因です。このように、鼻腔拡大器は鼻の通り道を拡大することで、鼻づまりを解消し、より良い空気の流れと呼吸を促進する非侵襲的な方法を記載しています。さらに、呼吸パターン、睡眠の質、その他の測定基準を監視するために、特定の外付け鼻孔拡大器は、ウェアラブル健康技術の増加傾向に沿ったセンサーまたはネットワーク要素を組み込んでいます。したがって、エンドユーザーはこのデータから呼吸器全体の健康状態や鼻の気流についてより詳しく知ることができます。

しかし、これらの拡大器のコストと入手しやすさが市場の成長を妨げています。一方、技術の進歩、睡眠時無呼吸症候群の有病率の増加、いびきは、外部鼻孔拡張器市場の機会を促進すると予想されます。例えば、世界の医療機器メーカーであるRhinomedは、鼻からの薬剤投与、睡眠の質、上気道疾患の診断、呼吸を改善します。MuteTMは、鼻を通る気流を平均38％増加させることで、いびきの頻度と強さを軽減し、朝の爽快感をともに向上させることができます。ユーザートライアルによると、いびきをかいている人は、パートナーの睡眠の質と自分の呼吸の質の両方を高めていることを知り、安心して眠ることができます。

セグメンテーション概要

外部鼻孔拡張器市場は、用途、エンドユーザー、流通チャネル、地域に区分されます。用途に基づき、市場はいびき、睡眠時無呼吸、鼻づまり、その他に分けられます。エンドユーザー別では、成人と小児に二分されます。流通チャネル別では、オンラインチャネルとオフラインチャネルに分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

競合分析

本レポートはカスタマイズが可能です（別途費用と期間がかかりますので、詳細は営業担当者にお問い合わせください）。

  • 国、地域、世界レベルでの患者/疫学データ
  • 規制ガイドライン
  • 顧客の関心に応じた追加企業プロファイル
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 外部鼻孔拡張器市場：用途別

  • 市場概要
  • いびき
  • 睡眠時無呼吸症候群
  • 鼻づまり
  • その他

第5章 外部鼻孔拡張器市場：エンドユーザー別

  • 市場概要
  • 成人
  • 小児

第6章 外部鼻孔拡張器市場：流通チャネル別

  • 市場概要
  • オフライン
  • オンライン

第7章 外部鼻孔拡張器市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の外部鼻孔拡張器市場
    • カナダの外部鼻孔拡張器市場
    • メキシコの外部鼻孔拡張器市場
  • 欧州
    • 主要市場動向と機会
    • フランスの外部鼻孔拡張器市場
    • ドイツの外部鼻孔拡張器市場
    • イタリアの外部鼻孔拡張器市場
    • スペインの外部鼻孔拡張器市場
    • 英国の外部鼻孔拡張器市場
    • その他の欧州の外部鼻孔拡張器市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国の外部鼻孔拡張器市場
    • 日本の外部鼻孔拡張器市場
    • インドの外部鼻孔拡張器市場
    • 韓国の外部鼻孔拡張器市場
    • オーストラリアの外部鼻孔拡張器市場
    • その他のアジア太平洋の外部鼻孔拡張器市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの外部鼻孔拡張器市場
    • 南アフリカの外部鼻孔拡張器市場
    • サウジアラビアの外部鼻孔拡張器市場
    • その他のラテンアメリカ・中東・アフリカの外部鼻孔拡張器市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • GlaxoSmithKline Plc
  • HealthRight Products LLC
  • Zhongshan Hongze Medical Technology Co., Ltd.
  • Permira I.P Limited
  • Health Right Products LLC
  • AirWare Labs
  • Splintek Inc
  • Scandinavian Formulas
  • Tomed GmbH
  • Rhinomed Limited
目次
Product Code: A42161

The global external nasal dilator market was valued at $98.3 million in 2023, and is projected to reach $162.4 million by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

An external nasal dilator is an innovative device designed to enhance the nasal airflow by gently opening the nasal passages from the outside. This device is especially beneficial for people who have sleep apnea, nasal congestion, snoring, or who want to breathe better when exercising. An external nasal dilator is designed to alleviate airflow constraints to improve breathing and general health.

The growth of the global external nasal dilator market is driven by several factors such as surge in the prevalence of sleep apnea, increasing popularity and adoption of external nasal dilators for, nasal congestion, snoring, or who want to breathe better when exercising. In addition, allergies, colds, sinusitis, and anatomical anomalies are major causes of nasal congestion. Thus, by enlarging the nasal passageways, external nasal dilators provide a non-invasive way to relieve nasal congestion and facilitate better airflow and breathing. Furthermore, to monitor breathing patterns, sleep quality, and other metrics, certain external nasal dilators are incorporating sensors or networking elements in line with the growing trend of wearable health technology. Thus, end users can learn more about their overall respiratory health and nasal airflow from this data.

However, cost and accessibility of these dilators hinder the growth of the market. On the other hand, technological advancements, increasing prevalence of sleep apnea, snoring is expected to drive the external nasal dilator market opportunity. For instance, the global medical device manufacturer Rhinomed improves nasal medication administration, sleep quality, upper respiratory disease diagnostics, and respiration. By increasing airflow through the nose by 38% on average, MuteTM can lessen the frequency and intensity of snoring and improve both of your morning feelings of refreshment. According to user trials, snorers can sleep easily knowing that they're enhancing both the quality of their partner's sleep and their own breathing.

Segmentation Overview

The external nasal dilator market is segmented into application, end user, distribution channel, and region. Depending on the application, the market is divided into snoring, sleep apnea, nasal congestion, and others. As per end user, it is bifurcated into adults and pediatric. According to distribution channel, the market is classified into online channel and offline channel. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Analysis

The major players operating in the external nasal dilator industry include GlaxoSmithKline Plc, HealthRight Products LLC, and Zhongshan Hongze Medical Technology Co., Ltd. Other players in the market are Permira I.P Limited, Health Right Products LLC, AirWare Labs., ?Splintek Inc, Scandinavian Formulas, Tomed GmbH, Creganna, Nasilator, Hubei YJT Technology Co., Ltd, Rhinomed Limited, Nasilator, Nasanita, ?SHREYAAS HEALTH CARE PVT LTD., and Walgreen Co. These companies have been active in adopting different tactics to maintain their position in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Application

  • Snoring
  • Sleep apnea
  • Nasal congestion
  • Others

By End User

  • Adults
  • Pediatric

By Distribution Channel

  • Offline
  • Online

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • GlaxoSmithKline Plc
    • HealthRight Products LLC
    • Zhongshan Hongze Medical Technology Co., Ltd.
    • Permira I.P Limited
    • Health Right Products LLC
    • AirWare Labs
    • Splintek Inc
    • Scandinavian Formulas
    • Tomed GmbH
    • Rhinomed Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: EXTERNAL NASAL DILATOR MARKET, BY APPLICATION

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Application
  • 4.2. Snoring
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Sleep Apnea
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Nasal Congestion
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: EXTERNAL NASAL DILATOR MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Adults
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Pediatric
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: EXTERNAL NASAL DILATOR MARKET, BY DISTRIBUTION CHANNEL

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Distribution Channel
  • 6.2. offline
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Online
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: EXTERNAL NASAL DILATOR MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Application
    • 7.2.3. Market Size and Forecast, By End User
    • 7.2.4. Market Size and Forecast, By Distribution Channel
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. External Nasal Dilator Market
      • 7.2.6.1. Market Size and Forecast, By Application
      • 7.2.6.2. Market Size and Forecast, By End User
      • 7.2.6.3. Market Size and Forecast, By Distribution Channel
    • 7.2.7. Canada External Nasal Dilator Market
      • 7.2.7.1. Market Size and Forecast, By Application
      • 7.2.7.2. Market Size and Forecast, By End User
      • 7.2.7.3. Market Size and Forecast, By Distribution Channel
    • 7.2.8. Mexico External Nasal Dilator Market
      • 7.2.8.1. Market Size and Forecast, By Application
      • 7.2.8.2. Market Size and Forecast, By End User
      • 7.2.8.3. Market Size and Forecast, By Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Application
    • 7.3.3. Market Size and Forecast, By End User
    • 7.3.4. Market Size and Forecast, By Distribution Channel
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France External Nasal Dilator Market
      • 7.3.6.1. Market Size and Forecast, By Application
      • 7.3.6.2. Market Size and Forecast, By End User
      • 7.3.6.3. Market Size and Forecast, By Distribution Channel
    • 7.3.7. Germany External Nasal Dilator Market
      • 7.3.7.1. Market Size and Forecast, By Application
      • 7.3.7.2. Market Size and Forecast, By End User
      • 7.3.7.3. Market Size and Forecast, By Distribution Channel
    • 7.3.8. Italy External Nasal Dilator Market
      • 7.3.8.1. Market Size and Forecast, By Application
      • 7.3.8.2. Market Size and Forecast, By End User
      • 7.3.8.3. Market Size and Forecast, By Distribution Channel
    • 7.3.9. Spain External Nasal Dilator Market
      • 7.3.9.1. Market Size and Forecast, By Application
      • 7.3.9.2. Market Size and Forecast, By End User
      • 7.3.9.3. Market Size and Forecast, By Distribution Channel
    • 7.3.10. UK External Nasal Dilator Market
      • 7.3.10.1. Market Size and Forecast, By Application
      • 7.3.10.2. Market Size and Forecast, By End User
      • 7.3.10.3. Market Size and Forecast, By Distribution Channel
    • 7.3.11. Rest of Europe External Nasal Dilator Market
      • 7.3.11.1. Market Size and Forecast, By Application
      • 7.3.11.2. Market Size and Forecast, By End User
      • 7.3.11.3. Market Size and Forecast, By Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Application
    • 7.4.3. Market Size and Forecast, By End User
    • 7.4.4. Market Size and Forecast, By Distribution Channel
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China External Nasal Dilator Market
      • 7.4.6.1. Market Size and Forecast, By Application
      • 7.4.6.2. Market Size and Forecast, By End User
      • 7.4.6.3. Market Size and Forecast, By Distribution Channel
    • 7.4.7. Japan External Nasal Dilator Market
      • 7.4.7.1. Market Size and Forecast, By Application
      • 7.4.7.2. Market Size and Forecast, By End User
      • 7.4.7.3. Market Size and Forecast, By Distribution Channel
    • 7.4.8. India External Nasal Dilator Market
      • 7.4.8.1. Market Size and Forecast, By Application
      • 7.4.8.2. Market Size and Forecast, By End User
      • 7.4.8.3. Market Size and Forecast, By Distribution Channel
    • 7.4.9. South Korea External Nasal Dilator Market
      • 7.4.9.1. Market Size and Forecast, By Application
      • 7.4.9.2. Market Size and Forecast, By End User
      • 7.4.9.3. Market Size and Forecast, By Distribution Channel
    • 7.4.10. Australia External Nasal Dilator Market
      • 7.4.10.1. Market Size and Forecast, By Application
      • 7.4.10.2. Market Size and Forecast, By End User
      • 7.4.10.3. Market Size and Forecast, By Distribution Channel
    • 7.4.11. Rest of Asia-Pacific External Nasal Dilator Market
      • 7.4.11.1. Market Size and Forecast, By Application
      • 7.4.11.2. Market Size and Forecast, By End User
      • 7.4.11.3. Market Size and Forecast, By Distribution Channel
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Application
    • 7.5.3. Market Size and Forecast, By End User
    • 7.5.4. Market Size and Forecast, By Distribution Channel
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil External Nasal Dilator Market
      • 7.5.6.1. Market Size and Forecast, By Application
      • 7.5.6.2. Market Size and Forecast, By End User
      • 7.5.6.3. Market Size and Forecast, By Distribution Channel
    • 7.5.7. South Africa External Nasal Dilator Market
      • 7.5.7.1. Market Size and Forecast, By Application
      • 7.5.7.2. Market Size and Forecast, By End User
      • 7.5.7.3. Market Size and Forecast, By Distribution Channel
    • 7.5.8. Saudi Arabia External Nasal Dilator Market
      • 7.5.8.1. Market Size and Forecast, By Application
      • 7.5.8.2. Market Size and Forecast, By End User
      • 7.5.8.3. Market Size and Forecast, By Distribution Channel
    • 7.5.9. Rest of LAMEA External Nasal Dilator Market
      • 7.5.9.1. Market Size and Forecast, By Application
      • 7.5.9.2. Market Size and Forecast, By End User
      • 7.5.9.3. Market Size and Forecast, By Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. GlaxoSmithKline Plc
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. HealthRight Products LLC
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Zhongshan Hongze Medical Technology Co., Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Permira I.P Limited
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Health Right Products LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. AirWare Labs
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Splintek Inc
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Scandinavian Formulas
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Tomed GmbH
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Rhinomed Limited
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments